Table 3.
Genotypic and allelic frequencies between the T2DM and control groups for the VDR gene polymorphisms.
| Polymorphisms | T2DM | Control | p | OR | CI 95% | |
|---|---|---|---|---|---|---|
|
ApaI
(rs7975232) |
Genotype | |||||
| AA | 60 (59.4%) | 38 (61.3%) | 0.474 | 0.395 | 0.080–1.959 | |
| AC | 33 (32.7%) | 22 (35.5%) | 0.375 | 0.073–1.935 | ||
| CC | 8 (7.9%) | 2 (3.2%) | Reference | |||
| Allele | ||||||
| A | 153 (75.7%) | 98 (79.0%) | 0.493 | 0.828 | 0.466–1.467 | |
| C | 49 (24.5%) | 26 (21.0%) | ||||
|
BsmI
(rs1544410) |
Genotype | |||||
| AA | 16 (15.8%) | 9 (14.5%) | 0.843 | 0.988 | 0.370–2.639 | |
| AG | 49 (48.5%) | 33 (53.2%) | 0.825 | 0.409–1.665 | ||
| GG | 36 (35.6%) | 20 (32.3%) | Reference | |||
| Allele | ||||||
| A | 81 (40.1%) | 51 (41.1%) | 0.854 | 0.958 | 0.593–1.550 | |
| G | 121 (59.9%) | 73 (58.9%) | ||||
|
FokI
(rs10735810) |
Genotype | |||||
| CC | 61 (60.4%) | 31 (50.0%) | 0.430 | 1.530 | 0.521–4.499 | |
| CT | 31 (30.7%) | 24 (38.7%) | 1.005 | 0.327–3.086 | ||
| TT | 9 (8.9%) | 7 (11.3%) | Reference | |||
| Allele | ||||||
| C | 153 (75.7%) | 86 (69.4%) | 0.206 | 1.380 | 0.812–2.342 | |
| T | 49 (24.5%) | 38 (30.6%) | ||||
|
TaqI
(rs731236) |
Genotype | |||||
| CC | 10 (9.9%) | 9 (14.5%) | 0.404 | 0.530 | 0.187–1.500 | |
| CT | 47 (46.5%) | 32 (51.6%) | 0.701 | 0.353–1.393 | ||
| TT | 44 (43.6%) | 21 (33.9%) | Reference | |||
| Allele | ||||||
| C | 67 (33.2%) | 50 (40.3%) | 0.191 | 0.735 | 0.450–1.199 | |
| T | 135 (66.8%) | 74 (59.7%) | ||||
T2DM (Type 2 diabetes mellitus). The variables were presented as an absolute value (percentage of total). p < 0.05 was considered statistically significant; Chi-square (x2) test.